24 citations
,
June 2020 in “Journal of the American Academy of Dermatology” This study reported that during the COVID-19 pandemic, online searches for general dermatologic conditions returned to prepandemic levels, while interest in premalignant, cancerous conditions, and cosmetic procedures remained low.
2 citations
,
April 2025 in “BMC Infectious Diseases” According to this study, nearly one-third of the participants experienced Long COVID, highlighting ongoing concerns about the disease's long-term implications despite the pandemic being under control.
In this large retrospective study, patients using compounded topical finasteride and minoxidil through a telehealth platform for male androgenetic alopecia reported high satisfaction and low incidence of side effects, with no need for higher care or treatment discontinuation due to adverse reactions.
December 2025 in “JMIR Dermatology” This study observed that patients using a novel topical combination of finasteride and minoxidil for male androgenetic alopecia reported high satisfaction and good tolerance, with few side effects and no need for higher-level care, despite limitations such as retrospective data and no control group.
7 citations
,
April 2021 in “Journal of The American Academy of Dermatology” This study found that the implementation of the SAVe teledermatology model increased access to dermatologic care during COVID-19, reducing referral wait times significantly compared to in-person visits.